Skip to Content

PGY2 Oncology Pharmacy Residency

The Division of Pharmacy at The University of Texas MD Anderson Cancer Center offers an ASHP accredited one-year PGY2 residency hematology/oncology. The Cancer Center has 600+ inpatient beds and over 5100+ outpatient clinic visits daily. The residency program is heavily weighted in patient care activities designed to develop expertise and clinical competence in pharmacotherapeutic aspects of acute and ambulatory cancer. Through required and elective rotations in a variety of focused hematology/oncology services, the resident will refine his/her clinical problem-solving skills in cancer management and supportive care. This training will prepare the resident to provide comprehensive clinical pharmacy services to the oncology population and to investigate therapeutic questions related to the care of cancer patients. Under the direction of Andrea Landgraf, Pharm.D, BCOP, and the clinical pharmacy staff at MD Anderson, the resident will:

  • Provide comprehensive, pharmacotherapeutic patient management as a member of the following teams:
    • Adult Leukemia
    • Stem Cell Transplant
    • Gastrointestinal Oncology
    • Gynecologic Oncology
    • Lymphoma/Myeloma
    • Breast Medical Oncology
    • Thoracic Oncology
    • Genitourinary Oncology
    • Infusion Center
    • Palliative Care Elective
    • Pediatric Heme/Onc Elective
    • Other Electives
  • Participate in oncology-focused Drug Information and Drug Use Policy
  • Provide education to patients, pharmacy staff, medical and nursing staff, and pharmacy students
  • Participate in clinical research and Investigational Pharmacy Services
  • Refine presentation and publication skills

Program Director

Andrea Landgraf Oholendt, Pharm.D., BCOP 
Director, PGY2 Oncology Pharmacy Residency 
Division of Pharmacy 
The University of Texas 
MD Anderson Cancer Center 
1515 Holcombe Blvd. – Unit 90 
Houston, TX. 77030-4009

Telephone: 713-792-4552
E-mail: anlandgr@mdanderson.org

Qualifications

Required: Pharm.D. degree; completion of an ASHP-accredited PGY1 Pharmacy Residency; licensure in the state of Texas.

Additional Program Information

Video! - PGY2 Oncology Program Overview

Frequently Asked Questions

Oncology Residency Program Outline

Oncology Residency Responsibilities

Application Information

Applications must be submitted by December 31. Please contact the program director prior to starting the application process.

Application Instructions

Institutional Information

Division of Pharmacy Overview

Quick Facts

Who was MD Anderson


© 2014 The University of Texas MD Anderson Cancer Center